A study by Liu et al. using 50 matched tumor, plasma and sputum samples showed that CDKN2A/p16 hypermethylation is detected in 84% of tumors, and 76% of sputum samples from the same patients, demonstrating that this remote medium is potentially effective in detecting lung cancer [55]. The gene discussed is CDKN2A; the disease is neoplasm.